GlassScriptPhysician profile
Sara M Prusinski
NPI 1629147566
$1,537.37
in general payments reported to CMS, 2019-2025
16 companies · $332 in 2025
The $332 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2020: $106 · 2021: $194 · 2022: $143 · 2023: $150 · 2024: $481 · 2025: $332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $945 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $944.87 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $262.51 | 2021-2025 | Precision7, Rocklatan, Hydrus Microstent |
| Coopervision INC. | $242.85 | 2022-2025 | Myday Contact Lens |
| Biotissue Holdings INC. | $181.94 | 2023-2025 | |
| Glaukos Corporation | $146.06 | 2024 | Idose |
| Bausch & Lomb Americas INC. | $142.86 | 2023-2024 | Infuse, Revive, Zenlens |
| Mallinckrodt Hospital Products INC. | $135.26 | 2025 | Acthar |
| Aerie Pharmaceuticals, INC. | $118.17 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $87.02 | 2021 | |
| Optos, INC. | $64.76 | 2020 | |
| Abb Con-Cise Optical Group LLC | $41.34 | 2020 | |
| Rxsight INC | $28.42 | 2024 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Injector Handpiece |
| Oyster Point Pharma, INC. | $19.73 | 2023 | Tyrvaya |
| Johnson & Johnson Vision Care, INC. | $19.61 | 2025 | |
| Abbvie INC. | $16.92 | 2022 | |
| Harrow Eye, LLC | $16.20 | 2024 | Vevye |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $13.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Prusinski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.